AstraZeneca (CHIX:AZNL) Cyclically Adjusted Book per Share: £15.89 (As of Mar. 2026)


CHIX:AZNL AstraZeneca PLC CHIX:AZNL
88 GF Score
Price £129.11
GF Value £134.94
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is AstraZeneca Cyclically Adjusted Book per Share?

AstraZeneca CHIX:AZNL -2.37% 88 Cyclically Adjusted Book per Share is £15.89 as of Mar. 2026. GuruFocus rates CHIX:AZNL with a GF Score™ of 88/100 and a GF Value™ of £134.94 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

AstraZeneca's adjusted book value per share for the three months ended in Mar. 2026 was £22.891. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is £15.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, AstraZeneca's average Cyclically Adjusted Book Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of AstraZeneca was 12.50% per year. The lowest was -0.90% per year. And the median was 5.70% per year.

As of today (2026-07-13), AstraZeneca's current stock price is £129.11. AstraZeneca's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was £15.89. AstraZeneca's Cyclically Adjusted PB Ratio of today is 8.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 4.21. And the median was 7.89.


AstraZeneca  (CHIX:AZNl) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AstraZeneca's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=129.11/15.89
=8.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 4.21. And the median was 7.89.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


AstraZeneca Cyclically Adjusted Book per Share Related Terms


AstraZeneca Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for AstraZeneca's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Cyclically Adjusted Book per Share Chart

AstraZeneca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.50 12.04 12.91 14.02 15.41

AstraZeneca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.32 14.83 15.12 15.41 15.89

CHIX:AZNL vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Cyclically Adjusted PB Ratio falls into.


CHIX:AZNL
88GF Score
AstraZeneca PLC CHIX:AZNL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AstraZeneca Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AstraZeneca's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=22.891/140.8000*140.8000
=22.891

Current CPI (Mar. 2026) = 140.8000.

AstraZeneca Quarterly Data

Book Value per Share CPI Adj_Book
201606 7.530 101.000 10.497
201609 7.864 101.500 10.909
201612 9.404 102.200 12.956
201703 8.310 102.700 11.393
201706 8.424 103.500 11.460
201709 8.131 104.300 10.976
201712 8.814 105.000 11.819
201803 7.301 105.100 9.781
201806 7.507 105.900 9.981
201809 7.208 106.600 9.521
201812 7.774 107.100 10.220
201903 6.066 107.000 7.982
201906 8.149 107.900 10.634
201909 7.492 108.400 9.731
201912 7.633 108.500 9.905
202003 6.637 108.600 8.605
202006 7.451 108.800 9.642
202009 7.174 109.200 9.250
202012 8.854 109.400 11.395
202103 7.925 109.700 10.172
202106 8.514 111.400 10.761
202109 18.677 112.400 23.396
202112 19.059 114.700 23.396
202203 17.801 116.500 21.514
202206 18.830 120.500 22.002
202209 20.021 122.300 23.050
202212 19.620 125.300 22.047
202303 19.028 126.800 21.129
202306 19.108 129.400 20.791
202309 19.392 130.100 20.987
202312 19.948 130.500 21.522
202403 19.010 131.600 20.339
202406 20.033 133.000 21.208
202409 19.857 133.500 20.943
202412 20.813 135.100 21.691
202503 20.491 136.100 21.199
202506 21.260 138.400 21.629
202509 21.904 138.900 22.204
202512 23.443 139.900 23.594
202603 22.891 140.800 22.891

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of £15.89 mean?
AstraZeneca (CHIX:AZNL) has a Cyclically Adjusted Book per Share of £15.89 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AstraZeneca and its competitors.
Is AstraZeneca's Cyclically Adjusted Book per Share too high?
AstraZeneca's current Cyclically Adjusted Book per Share is £15.89. Overall, AstraZeneca has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's Cyclically Adjusted Book per Share compare to LLY and JNJ?
AstraZeneca's Cyclically Adjusted Book per Share of £15.89 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AstraZeneca and its competitors. AstraZeneca's current Cyclically Adjusted Book per Share is £15.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
Based on GuruFocus' analysis, AstraZeneca (CHIX:AZNL) is currently considered Fairly Valued. The stock's GF Value™ is £134.94, compared to a current price of £129.11 — trading 4.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is £15.89. AstraZeneca's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For AstraZeneca (CHIX:AZNL), the current Cyclically Adjusted Book per Share is £15.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca (CHIX:AZNL) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be undervalued. The current stock price of £129.11 is trading 4.3% below its estimated GF Value™ of £134.94. GuruFocus considers AstraZeneca to be Fairly Valued.

Key valuation signals for CHIX:AZNL:

  • Cyclically Adjusted Book per Share: £15.89
  • GF Value™: £134.94 vs. price of £129.11 (4.3% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the CHIX:AZNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
88GF Score

Get the complete analysis for CHIX:AZNL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£129.11
Price
£134.94
GF Value